Drug
Simvastatin
Simvastatin: highest development phase Phase 3, developed by Biogen, Dr. Reddy's, Madrigal Pharmaceuticals. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Biogen, Dr. Reddy's, Madrigal Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Simvastatin NCT00242268 | Phase 3 | Relapsing Remitting Multiple Sclerosis |
| Simvastatin NCT01167894 | Phase 1 | Healthy |
| Simvastatin NCT02542969 | Phase 1 | Healthy |
Latest
No recent events.
Follow Simvastatin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.